Publications by authors named "Argyro Repa"

Claim this Profile
L
Long-term comparative analysis of secukinumab versus TNFα inhibitors in patients with spondyloarthritis: treatment persistence is differentially affected by disease phenotype, obesity and sex.
Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Sofia Pitsigavdaki, Eleni Kalogiannaki

Arthritis Res Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study.
Spyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, Ettore Silvagni, Argyro Repa

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients.
Sofia Flouda, Evgenia Emmanouilidou, Anastasios Karamanakos, Dimitra Koumaki, Dimitrios Katsifis-Nezis, Argyro Repa

Lupus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
Irini Flouri, Panagiota Goutakoli, Argyro Repa, Antonios Bertsias, Nestor Avgoustidis

Rheumatol Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki

RMD Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients.
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki

Cells· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities Burden and Implementation of the Treat-to-Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides.
Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Sofia Pitsigavdaki, Katerina Pateromichelaki

Mediterr J Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
Evgenia Emmanouilidou, Despoina Kosmara, Efrosini Papadaki, Vasileios Mastorodemos, Pantelis Constantoulakis, Argyro Repa

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Noemin Kapsala, Argyro Repa

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis.
Konstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, Paraskevi V Voulgari, Alexandros A Drosos, Argyro Repa

Front Med (Lausanne)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. 2022, , 4316.
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study.
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos

J Clin Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study.
Antonios Bertsias, Nestor Avgoustidis, Ioannis Papalopoulos, Argyro Repa, Nikolaos Kougkas

Arthritis Res Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
Dimitrios Psaltis, Loukas Settas, Athanasios Georgiadis, Eftichia Koukli, Andreas Bounas, Argyro Repa

Rheumatol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
Emmanouil Papastefanakis, Georgia Dimitraki, Georgia Ktistaki, Antonis Fanouriakis, Penny Karamaouna, Argyro Repa

Lupus· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, Myrto Nikoloudaki, Argyro Repa

Ann Rheum Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.
Konstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, Paraskevi V Voulgari, Alexandros A Drosos, Argyro Repa

Rheumatology (Oxford)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emotion regulation contributes to the well-being of patients with autoimmune diseases through illness-related emotions: A prospective study.
Evangelos C Karademas, Georgia Dimitraki, Emmanouil Papastefanakis, Georgia Ktistaki, Argyro Repa

J Health Psychol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus.
Christina Adamichou, Irini Flouri, Antonios Fanouriakis, Myrto Nikoloudaki, Dionysios Nikolopoulos, Argyro Repa

Mediterr J Rheumatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.
Nikolaos I Panousis, George K Bertsias, Halit Ongen, Irini Gergianaki, Maria G Tektonidou, Argyro Repa

Ann Rheum Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis.
Argyro Repa, Nestor Avgoustidis, Nikos Kougkas, George Bertsias, Michalis Zafiriou

Mediterr J Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital.
Nikolaos Kougkas, Nestor Avgoustidis, Argyro Repa, George Bertsias, Anastasios Eskitzis

Mediterr J Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus.
Christina Adamichou, Dionysios Nikolopoulos, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Argyro Repa

Mediterr J Rheumatol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.
Nikolaos Kougkas, Antonis Fanouriakis, Ioannis Papalopoulos, George Bertsias, Nestor Avgoustidis, Argyro Repa

Rheumatology (Oxford)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis